دورية أكاديمية
Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice
| العنوان: | Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice |
|---|---|
| المؤلفون: | Lin, LishiAff1, IDs1152302100862x_cor1, Smit, Egbert F.Aff2, Aff3, de Langen, Adrianus J., van Balen, Dorieke E. M., Beijnen, Jos H.Aff1, Aff4, Huitema, Alwin D. R.Aff1, Aff5, Aff6 |
| المصدر: | Targeted Oncology. 17(1):53-59 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 17762596 1776260X |
|---|---|
| DOI: | 10.1007/s11523-021-00862-x |